61703-161-05 |
61703-161 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
20241104 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
5 VIAL, MULTI-DOSE in 1 CARTON (61703-161-05) / 2 mL in 1 VIAL, MULTI-DOSE (61703-161-02) |
61703-408-25 |
61703-408 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
20131111 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (61703-408-25) / 40 mL in 1 VIAL, SINGLE-DOSE |
61703-408-41 |
61703-408 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
20010226 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (61703-408-41) / 40 mL in 1 VIAL, SINGLE-DOSE |
61703-350-38 |
61703-350 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
20050727 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-38) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-37) |
61703-350-10 |
61703-350 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
20140925 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-10) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-09) |
61703-124-40 |
61703-124 |
HUMAN PRESCRIPTION DRUG |
Methotrexate |
Methotrexate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
20221017 |
N/A |
NDA |
NDA011719 |
Hospira, Inc. |
METHOTREXATE SODIUM |
25 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (61703-124-40) / 40 mL in 1 VIAL, SINGLE-DOSE |